What is the price of Entia Biosciences, Inc. (ERGO)

The price of Entia Biosciences, Inc. (ERGO) is $0.0002

What is the market cap of Entia Biosciences, Inc. (ERGO)

The market cap of Entia Biosciences, Inc. (ERGO) is $6.73K

Entia Biosciences, Inc. (ERGO) Dividend Yield

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.

Year	Dividend Yield	Change
Not enough data for the provided dates.

Year

Dividend Yield

Change

Not enough data for the provided dates.

Company	Dividend Yield	Country
Royalty Pharma plc RPRX.US	1.56%	US
Swedish Orphan Biovitrum AB SOBI.ST	0.00%	SE
Ipsen S.A. IPN.PA	0.00%	FR
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	0.00%	IT
Corcept Therapeutics Incorporated CORT.US	0.00%	US

Company

Dividend Yield

Country